MindMed And Other Psychedelic Stocks Brace For FDA's Decision On MDMA TherapySeeking Alpha • 08/07/24
MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business UpdateBusiness Wire • 08/06/24
MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)Business Wire • 07/17/24
MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceBusiness Wire • 06/21/24
MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)Business Wire • 06/20/24
Is Mind Medicine MindMed (MNMD) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 06/14/24
MindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating FactorsSeeking Alpha • 06/05/24
Are Medical Stocks Lagging Mind Medicine MindMed (MNMD) This Year?Zacks Investment Research • 05/29/24